权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

NCI NCTN-Network Lead Academic Participating Site at UPMC Hillman Cancer Center

UPMC 希尔曼癌症中心 NCI NCTN 网络领导学术参与站点

基本信息

批准号：
10359765
负责人：
ADAM M BRUFSKY
金额：
$ 91.11万
依托单位：
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-05-01 至 2025-02-28
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10359765
关键词：
Academic Medical Centers Address Adult American College of Radiology Imaging Network Cancer Center Cancer Patient Clinical Clinical Data Clinical Investigator Clinical Protocols Clinical Research Clinical Trials Clinical Trials Network Comprehensive Cancer Center Country Development Eastern Cooperative Oncology Group Ensure Genotype Goals Infrastructure Lead Leadership Medical Mentors Minority National Cancer Institute National Clinical Trials Network New York Ohio Oncology Participant Patients Pennsylvania Performance Phase Physicians Positioning Attribute Principal Investigator Process Protocols documentation Publications Reporting Research Personnel Resources Rural Science Services Site Special Population Structure University of Pittsburgh Cancer Institute Work cancer care cancer research center director clinical investigation data management improved programs rare cancer skills translational scientist

项目摘要

Project Summary/Abstract The goal of the National Clinical Trials Network (NCTN) Lead Academic Participating Site at UPMC Hillman Cancer Center, is to increase our level of participation in conceptualization, development, activation, performance, and reporting of the late-phase clinical trials of the NRG Oncology, ECOG-ACRIN, and Alliance for Clinical Trials in Oncology Network Groups. This will be accomplished by enhancing the quality of our scientific and administrative leadership; increasing accruals to NCTN trials, with special efforts directed at minority, rural and other special populations; improving our processes for rapid activation of new trials, with special efforts directed at trials for rare cancers and genotypically-defined subpopulations; and mentoring junior investigators in how to conduct phase 2 and phase 3 NCTN trials, and in the administrative, scientific, and interpersonal skills needed for advancing into positions of leadership within the NCTN and National Cancer Institute.

项目总结/摘要国家临床试验网络（NCTN）领导学术参与中心在UPMC希尔曼的目标癌症中心，是为了提高我们的参与水平，在概念化，发展，激活， NRG Oncology、ECOG-ACRIN和ECOG-ACRIN的晚期临床试验的性能和报告肿瘤学临床试验联盟网络组。这将通过提高质量来实现我们的科学和行政领导;增加应计NCTN试验，特别努力针对少数民族、农村和其他特殊人群;改进我们的程序，试验，特别是针对罕见癌症和基因型定义的亚群的试验;以及指导初级研究人员如何进行2期和3期NCTN试验，以及行政管理，科学和人际交往能力，需要推进到NCTN内的领导地位，美国国家癌症研究所.